MuLV IN mutants responsive to HDAC inhibitors enhance transcription from unintegrated retroviral DNA

Virology

Volumn 426, Issue 2, 2012, Pages 188-196

  Schneider, William M ^a,b   Wu, Dai Tze ^a   Amin, Vaibhav ^a   Aiyer, Sriram ^a   Roth, Monica J ^a  

^a RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

HDAC inhibitors; Intasome; Integrase; MuLV IN; Non integrating vectors; Pre integration complex, PIC

Indexed keywords

INTEGRASE; MUTANT PROTEIN; PROTEIN P300; TRICHOSTATIN A; VIRUS DNA;

ACETYLATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; DNA INTEGRATION; DNA TRANSCRIPTION; ENZYME ACTIVE SITE; ENZYME SUBSTRATE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MOLONEY LEUKEMIA ONCOVIRUS; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SEQUENCE HOMOLOGY; VIRUS MUTANT;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; DNA, VIRAL; DOGS; GENE EXPRESSION REGULATION, VIRAL; HISTONE DEACETYLASE INHIBITORS; HUMANS; INTEGRASES; MICE; MOLECULAR SEQUENCE DATA; MOLONEY MURINE LEUKEMIA VIRUS; RETROVIRIDAE INFECTIONS; SEQUENCE ALIGNMENT; TRANSCRIPTION, GENETIC; UP-REGULATION; VIRAL PROTEINS; VIRUS INTEGRATION;

HUMAN IMMUNODEFICIENCY VIRUS 1; MOLONEY MURINE LEUKEMIA VIRUS;

EID: 84857788410     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2012.01.034     Document Type: Article

References (64)

1. Albritton L.M., Tweng L., Scadden D., Cunningham J.M. A putative murine retrovirus receptor gene encodes a multiple membrane-spanning protein and confers susceptibility to virus infection. Cell 1989, 57:659-666.
2. Allouch A., Primio C.D., Alpi E., Lusic M., Arosio D., Giacca M., Cereseto A. The TRIM family protein KAP1 inhibits HIV-1 integration. Cell Host Microbe 2011, 9:484-495.
3. Banasik M.B., McCray P.B. Integrase-defective lentiviral vectors: progress and applications. Gene Therapy 2010, 17(2):150-157.
4. Barua S., Rege K. The influence of mediators of intracellular trafficking on transgene expression efficacy of polymer-plasmid DNA complexes. Biomaterials 2010, 31:5894-5902.
5. Bayer M., Kantor B., Cockrell A., Ma H., Zeithaml B., Li X., McCown T., Kafri T. A large U3 deletion causes increased in vivo expression from a nonintegrating lentiviral vector. Mol. Ther. 2008, 16:1968-1976.
6. Bowerman B., Brown P.O., Bishop J.M., Varmus H.E. A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev. 1989, 3:469-478.
7. Bruce J.W., Ahlquist P., Young J.A. The host cell sulfonation pathway contributes to retroviral infection at a step coincident with provirus establishment. PLoS Pathog. 2008, 4:e1000207.
8. Bukrinsky M.I., Sharova N., McDonald T.L., Pushkarskaya T., Tarpley W.G., Stevenson M. Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc. Natl. Acad. Sci. U. S. A. 1993, 90:6125-6129.
9. Bupp K., Roth M.J. Altering retroviral tropism using a random-display envelope library. Mol. Ther. 2002, 5:329-335.
10. Butler S.L., Johnson E.P., Bushman F.D. Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J. Virol. 2002, 76(8):3739-3747.
11. Carrozza M.J., Utley R.T., Workman J.L., Cote J. The diverse functions of histone acetyltransferase complexes. Trends Genet. 2003, 19:321-329.
12. Cereseto A., Manganaro L., Gutierrez M.I., Terreni M., Fittipaldi A., Lusic M., Marcello A., Giacca M. Acetylation of HIV-1 integrase by p300 regulates viral integration. EMBO J. 2005, 24:3070-3081.
13. Chen J.C.-H., Krucinski J., Miercke L.J.W., Finer-Moore J.S., Tang A.H., Leavitt A.D., Stroud R.M. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:8233-8238.
14. Chen H., Wei S.Q., Engelman A. Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome. J. Biol. Chem. 1999, 274:17358-17364.
15. Chen C.-C., Rivera A., Ron N., Dougherty J.P., Ron Y. A gene therapy approach for treating T-cell-mediated autoimmune diseases. Blood 2001, 97:886-894.
16. Cherepanov P., Maertens G., Proost P., Devreese B., Van Beeumen J., Engelborghs Y., De Clercq E., Debyser Z. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J. Biol. Chem. 2003, 278:372-381.
17. Colicelli J., Goff S.P. Mutants and pseudorevertants of Moloney murine leukemia virus with alterations at the integration site. Cell 1985, 42:573-580.
18. Colicelli J., Goff S.P. Sequence and spacing requirements of a retrovirus integration site. J. Mol. Biol. 1988, 199:47-59.
19. Cosset F.-L., Takeuchi Y., Battini J.-L., Weiss R.A., Collins K.L.M. High-titer packaging cells producing recombinant retroviruses resistant to human serum. J. Virol. 1995, 69:7430-7436.
20. Craigie R., Fujiwara T., Bushman F. The IN protein of Moloney murine leukemia virus processes the viral DNA ends and accomplishes their integration in vitro. Cell 1990, 62:829-837.
21. Dar M., Monel B., Krishnan L., Shun M., Nunzio F.D., Helland D., Engelman A. Biochemical and virological analysis of the 18-residue C-terminal tail of HIV-1 integrase. Retrovirology 2009, 6:94.
22. Donehower L.A., Varmus H.E. A mutant murine leukemia virus with a single missense codon in pol is defective in a function affecting integration. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:6461-6465.
23. Engelman A., Craigie R. Identification of conserved amino acid residues critical for human immunodeficiency virus type 1 integrase function in vitro. J. Virol. 1992, 66:6361-6369.
24. Engelman A., Englund G., Orenstein J.M., Martin M.A., Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 1995, 69:2729-2736.
25. Felkner R.H., Roth M.J. Mutational analysis of N-linked glycosylation sites of the SU protein of Moloney murine leukemia virus. J. Virol. 1992, 66:4258-4264.
26. Goff S.P., Traktman P., Baltimore D. Isolation and properties of Moloney murine leukemia virus mutants; use of a rapid assay for release of virion reverse transcriptase. J. Virol. 1981, 38:239-248.
27. Hacein-Bey-Abina S., Von Kalle C., Schmidt M., McCormack M.P., Wulffraat N., Leboulch P., Lim A., Osborne C.S., Pawliuk R., Morillon E., Sorensen R., Forster A., Fraser P., Cohen J.I., de Saint Basile G., Alexander I., Wintergerst U., Frebourg T., Aurias A., Stoppa-Lyonnet D., Romana S., Radford-Weiss I., Gross F., Valensi F., Delabesse E., Macintyre E., Sigaux F., Soulier J., Leiva L.E., Wissler M., Prinz C., Rabbitts T.H., Le Deist F., Fischer A., Cavazzana-Calvo M. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science 2003, 302:415-419.
28. Hare S., Gupta S.S., Valkov E., Engelman A., Cherepanov P. Retroviral intasome assembly and inhibition of DNA strand transfer. Nature 2010, 464:232-236.
29. Hare S., Vos A.M., Clayton R.F., Thuring J.W., Cummings M.D., Cherepanov P. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:20057-20062.
30. Jenuwein T., Allis C.D. Translating the histone code. Science 2001, 293:1074-1080.
31. Kantor B., Ma H., Webster-Cyriaque J., Monahan P.E., Kafri T. Epigenetic activation of unintegrated HIV-1 genomes by gut-associated short chain fatty acids and its implications for HIV infection. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:18786-18791.
32. Katz R.A., Merkel G., Kulkosky J., Leis J., Skalka A.M. The avian retroviral IN protein is both necessary and sufficient for integrative recombination in vitro. Cell 1990, 63:87-95.
33. Katz R.A., Jack-Scott E., Narezkina A., Palagin I., Boimel P., Kulkosky J., Nicolas E., Greger J.G., Skalka A.M. High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms. J. Virol. 2007, 81:2592-2604.
34. Krishnan L., Li X., Naraharisetty H.L., Hare S., Cherepanov P., Engelman A. Structure-based modeling of the functional HIV-1 intasome and its inhibition. Proc. Natl. Acad. Sci. 2010, 107:15910-15915.
35. Lee M.S., Craigie R. A previously unidentified host protein protects retroviral DNA from autointegration. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:1528-1533.
36. Lin C.W., Engelman A. The barrier-to-autointegration factor is a component of functional human immunodeficiency virus type 1 preintegration complexes. J. Virol. 2003, 77:5030-5036.
37. Llano M., Vanegas M., Fregoso O., Saenz D., Chung S., Peretz M., Poeschla E.M. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J. Virol. 2004, 78:9524-9537.
38. Lobel L.I., Goff S.P. Construction of mutants of Moloney murine leukemia virus by suppressor-linker insertion mutagenesis: positions of viable insertion mutations. Proc. Natl. Acad. Sci. U. S. A. 1984, 81:4149-4153.
39. McCutchan J.H., Pagano J.S. Enhancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J. Natl. Cancer Inst. 1968, 41:351-357.
40. Miller M.D., Farnet C.M., Bushman F.D. Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition. J. Virol. 1997, 71:5382-5390.
41. Mohammed K.D., Topper M.B., Muesing M.A. Sequential deletion of the integrase (Gag-Pol) carboxyl terminus reveals distinct phenotypic classes of defective HIV-1. J. Virol. 2011, 85:4654-4666.
42. Nightingale S.J., Hollis R.P., Pepper K.A., Petersen D., Yu X.J., Yang C., Bahner I., Kohn D.B. Transient gene expression by nonintegrating lentiviral vectors. Mol. Ther. 2006, 13:1121-1132.
43. O'Reilly L., Roth M.J. Second-site changes affect viability of amphotropic/ecotropic chimeric enveloped murine leukemia viruses. J. Virol. 2000, 74:899-913.
44. Pettersen E., Goddard T., Huang C., Couch G., Greenblatt D., Meng E., Ferrin T. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 2004, 25:1605-1612.
45. Philippe S., Sarkis C., Barkats M., Mammeri H., Ladroue C., Petit C., Jacques M., Serguera C. Lentiviral vectors with a defective integrase allow efficient and sustained transgene expression in vitro and in vivo. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:17684-17689.
46. Prizan-Ravid A., Elis E., Laham-Karam N., Selig S., Ehrlich M., Bacharach E. The Gag cleavage product, p12, is a functional constituent of the murine leukemia virus pre-integration complex. PLoS Pathog. 2010, 6:e1001183.
47. Rahim A.A., Wong A.M., Howe S.J., Buckley S.M., Acosta-Saltos A.D., Elston K.E., Ward N.J., Philpott N.J., Cooper J.D., Anderson P.N., Waddington S.N., Thrasher A.J., Raivich G. Efficient gene delivery to the adult and fetal CNS using pseudotyped non-integrating lentiviral vectors. Gene Ther. 2009, 16:509-520.
48. Roe T., Chow S.A., Brown P.O. 3'-end processing and kinetics of 5'-end joining during retroviral integration in vivo. J. Virol. 1997, 71:1334-1340.
49. Roth M.J. Mutational analysis of the carboxy terminus of the Moloney murine leukemia virus integration protein. J. Virol. 1991, 65:2141-2145.
50. Roth M.J., Schwartzberg P., Tanese N., Goff S.P. Analysis of mutations in the integration function of Moloney murine leukemia virus: effects on DNA binding and cutting. J. Virol. 1990, 64:4709-4717.
51. Seamon J.A., Adams M., Sengupta S., Roth M.J. Differential effects of C-terminal molecular tagged integrase on repication competent Moloney-murine leukemia virus. Virology 2000, 274:412-419.
52. Sloan R.D., Wainberg M.A. The role of unintegrated DNA in HIV infection. Retrovirology 2011, 8:52.
53. Soneoka Y., Cannon P.M., Ramsdale E.E., Griffiths J.C., Romano G., Kingsman M.S., Kingsman A.J. A transient three-plasmid expression system for the production of high titer retroviral vectors. Nucleic Acids Res. 1995, 23:629-633.
54. Steinrigl A., Nosek D., Ertl R., Günzburg W.H., Salmons B., Klein D. Mutations in the catalytic core or the C-terminus of murine leukemia virus (MLV) integrase disrupt virion infectivity and exert diverse effects on reverse transcription. Virology 2007, 362:50-59.
55. Tanese N., Roth M.J., Goff S.P. Analysis of retroviral pol gene products with antisera raised against fusion proteins produced in Escherichia coli. J. Virol. 1986, 59:328-340.
56. Terreni M., Valentini P., Liverani V., Gutierrez M.I., Primio C.D., Fenza A.D., Tozzini V., Allouch A., Albanese A., Giacca M., Cereseto A. GCN5-dependent acetylation of HIV-1 integrase enhances viral integration. Retrovirology 2010, 7:18.
57. Thomas C.E., Ehrhardt A., Kay M.A. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 2003, 4:346-358.
58. Topper M., Luo Y., Zhadina M., Mohammed K., Smith L., Muesing M.A. Posttranslational acetylation of the human immunodeficiency virus type 1 integrase carboxyl-terminal domain is dispensable for viral replication. J. Virol. 2007, 81:3012-3017.
59. Vanniasinkam T., Ertl H., Tang Q. Trichostatin-A enhances adaptive immune responses to DNA vaccination. J. Clin. Virol. 2006, 36:292-297.
60. Voelkel C., Galla M., Maetzig T., Warlich E., Kuehle J., Zychlinski D., Bode J., Cantz T., Schambach A., Baum C. Protein transduction from retroviral Gag precursors. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:7805-7810.
61. Wei S.Q., Mizuuchi K., Craigie R. A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration. EMBO J. 1997, 16:7511-7520.
62. Wei S.Q., Mizuuchi K., Craigie R. Footprints on the viral DNA ends in Moloney murine leukemia virus preintegration complexes reflect a specific association with integrase. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:10535-10540.
63. Wu X., Li Y., Crise B., Burgess S.M. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003, 300:1749-1751.
64. Yu S.S., Dan K., Chono H., Chatani E., Mineno J., Kato I. Transient gene expression mediated by integrase-defective retroviral vectors. Biochem. Biophys. Res. Commun. 2008, 368:942-947.